Modulation of endothelin-1-induced contractions by magnesium/calcium in porcine ciliary arteries by Dettmann, Eike et al.
Graefe's Arch Clin Exp Ophthalmol (1998)
236:47-51 © Springer-Verlag 1998
Eike S. Dettmann
Thomas F. Luscher
Josef Flammer
Ivan O. Haefliger
Modulation of endothelin-l-induced contractions
by magnesium/calcium in porcine ciliary arteries
Received: 10 January 1997
Revised version received: 2 April 1997
Accepted:8 April 1997
Presented in part as a poster at the
5th Congress of the European Glaucoma
Society, Paris, France, 19-22 June 1996
E.S. Dettmann • J. Flammer
I.O. Haefliger (®)
Laboratory of Ocular Pharmacology
and Physiology,
University Eye Hospital Basel,
Mittlere Strasse 91, P.O.
CH-4012 Basel, Switzerland
Tel. +41-61-265-8787;
fax: +41-61-265-8652
T.F. Liischer
Cardiology, University Hospital Zurich,
Switzerland
Abstract • Background: The pres-
ent study was performed to investi-
gate the influence of extracellular
magnesium on changes in contractile
tone induced by endothelin-1, and
on relaxations to bradykinin in
isolated porcine ciliary arteries.
• Methods: Vessels were studied in
a myograph system for measurement
of isometric forces.Concentration-
response curves (10-10-10-7 M) to
endothelin-1 were constructed in the
presence of different concentrations
(0, 1.2, 2, 10 mM) of magnesium
(MgSO4). Endothelin-l-precontract-
ed vessels ('10-8 M) were exposed to
magnesium (10-5-10-2 M) in the
presence or absence of either the
inhibitor of nitric oxide formation
L-NAME (-10-4 M), or different
concentrations of calcium (2.5, 5,
10 mM). In endothelin-l-precon-
tracted vessels (10-8 M), relaxations
to bradykinin (10-10-10 M) were
conducted in the presence of different
concentrations of magnesium (0, 1.2,
10 mM). • Results: Contractions to
endothelin- 1 were reduced only in the
presence of 10 mM magnesium.
(1.2 mM vs 10 mM, P = 0.001). In
endothelin-l-precontracted vessels,
magnesium evoked complete con-
centration-dependent relaxations
(pD2 = 3.1 ± 0.1), which were shifted
to the right by increasing extracellu-
lar concentrations of calcium (2.5 vs
5 mM, P < 0.05). L-NAME had no
influence on magnesium-induced re-
laxations. Relaxations to bradykinin
remained unaffected by changes in
extracellular magnesium concentra-
tions. • Conclusions: In a mecha-
nism which appears to be compatible
with a calcium-antagonist effect,
magnesium strongly modulates
changes in contractile tone evoked by
endothelin-1, but has no effect on
bradykinin-induced relaxations.
Introduction
Various endothelial-derived substances modulate vascular
tone. Among them are the potent vasoconstrictor, endo-
thelin-1, and the vasorelaxing factor, nitric oxide (NO)
[11, 12, 20, 23].
Endothelin-1, after binding to specific receptors on
vascular smooth muscle cells, activates phospholipase
C and leads - via formation of inositol triphosphate
and diacylglycerol - to an increase in intracellular calci-
um and eventually to a contraction [21, 29]. In some vas-
cular beds, the endothelin-l-induced intracellular calci-
um increase has been shown to be, in part, due to an in-
flux of extracellular calcium through voltage-operated
channels [10]. As a result, in certain vascular beds, cal-
cium antagonists are effective in inhibiting endothelin- 1-
induced contractions [15]. For example, in the ophthal-
mic circulation, modulation of endothelin-l-induced
contractions by calcium antagonists could be shown
[24, 27].
NO is formed from L-arginine by a specific NO syn-
thase in endothelial cells under basal conditions or after
activation by some agonists, such as bradykinin [20]. In
vascular smooth muscle cells, NO stimulates a guanylate
cyclase, which in turn increases intracellular cGMP con-
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centration and leads, by lowering the intracellular calcium
concentration, to a relaxation [28].
Extracellular magnesium concentration modulates vas-
cular contractile tone. In precontracted vessels, magne-
sium causes vasorelaxations, and contractions to various
agonists were attenuated in the presence of high concen-
trations of magnesium [1, 3, 6, 18, 31, 32]. These effects
have usually been attributed to a calcium-antagonist-like
mechanism [13, 14, 18] and it has been suggested that
magnesium is able to regulate calcium flux across the vas-
cular smooth muscle cell membranes. It has also been re-
ported that magnesium could interfere with the calcium
release from intracellular storage sites, as well as with
the basal formation and/or the release of NO [9, 17].
This study investigates, in isolated porcine ciliary arte-
ries, the influence of magnesium on contractions to endo-
thelin-1 and on NO-induced endothelium-dependent re-
laxations evoked by bradykinin [34].
Drugs
Bradykinin, L-NAME, indomethacin, and U46619 were obtained
from Sigma Chemical (St. Louis, Mo.), and endothelin-1 from No-
vabiochem (Laufigen, Switzerland). All drugs were dissolved in dis-
tilled water except U46619 and indomethacin, which were dissolved
in 10-5
 M Na2CO3, and endothelin-1, which was dissolved in Krebs
solution containing 0.05% bovine serum albumin. Concentrations
were expressed as final molar concentrations in the organ chamber.
Statistical analysis
Contractions were expressed as percentage of contraction to 100 mM
KCl and relaxations as percentage of the precontraction to endothe-
lin- 1 (10-s
 M). The concentration causing 50% of the maximal re-
sponse (EC50 value) was expressed as a negative log M concentra-
tion (pD2 value). Results are given as mean ± standard error of
the mean (mean ± SEM), and n equals the number of eyes (one
eye per animal). For statistical comparison analysis of variance
(ANOVA; Scheffe's F test) was used. A two-tailed P value smaller
than 0.05 was considered to be statistically significant.
Materials and methods
Blood-vessel preparation
Porcine eyes were obtained at a slaughterhouse just after death of
animals. In cold modified Krebs-Ringer solution (NaCI 118 mM,
KCl 4.7 mM, CaC12 2.5 mM, KH2PO4 1.2 mM, MgSO4 1.2 mM,
NaHCO3 25 mM, glucose 11.1 mM), ciliary arteries were isolated
and cut into 2-mm-long rings [25]. In an organ chamber, two 40-
µm stainless wires were passed through the vessel's lumen and at-
tached to a force transducer for isometric force measurement and
to a micromanipulator (Myo-Interface, JP Trading, Aarhus, Den-
mark). Vessels were left for 30 min for equilibration in the modified
Krebs-Ringer solution (95% 02, 5% CO2, 37 °C, and indomethacin
10-5 M to block prostaglandin synthesis). Vessels were then
stretched in a stepwise fashion to reach their optimal passive tension
(ca. 950 mg) [11, 24].Then vessels were exposed several times to
KC1 100 mM until they showed reproducible contractions (i.e. less
than 10% variation between two successive KCl-induced contrac-
tions). The endothelial function was considered to be intact if brady-
kinin (10-8-10-6 M) evoked more than 80% relaxation of a vessel
precontracted with the thromboxane A2 analog U46619 (10 -7 M).
Experimental protocol
In the presence of different concentrations of magnesium (0, 1.2, 2,
and 10 mM), concentration-response curves to ET-1 (10-10-10-7 M)
were constructed. Isotonicity was maintained by adjusting the NaCl
concentration. In another set of experiments endothelin-l-precon-
tracted vessels ('10-s M) were exposed to increasing concentrations
of MgC12 and/or MgSO4 (10-5-10-2 M): (a) in the presence or ab-
sence of the inhibitor of nitric oxide formation 1V G-nitro-L-arginine
methyl ester (L-NAME; 10 -4 M), and (b) in the presence of different
concentrations of Cat (2.5, 5, and 10 mM). In all these experiments,
the precontraction to endothelin-1 was achieved in a magnesium-
free medium. To rule out an osmolarity effect, a control was con-
ducted with NaCl (same osmolarity as MgSO4). Finally, after pre-
contracting vessels with endothelin-1 (, 10-8 M), a relaxation-re-
sponse curve to bradykinin (10 -10-10 M) was constructed in the
presence of different concentrations of magnesium (0, 1.2, and
10 mM). It has to be mentioned that concentrations of ET-1 were
adapted (10-8 M to 3x10 8  M) in order to reach equivalent levels
of precontraction.
Results
Magnesium modulates endothelin-l-induced contractions
In porcine ciliary arteries, endothelin-1-induced, under
control conditions (Mg2,
 1.2 mM), potent concentration-
dependent contractions, with a maximal effect of
111 ± 4% of KCI 100 mM contraction and a pD2
 value
of 7.9 ± 0.1 (Fig. 1). Responses were not significantly af-
fected by decreasing magnesium concentrations to 0 mM
or increasing to 2 mM. Only at a concentration of 10 mM
could a significant reduction of the maximal contractile
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Fig. 1 Effect of different extracellular MgSO4 concentrations on en-
dothelin-1-induced contractions. In comparison to control conditions
(1.2 mM), only at a concentration of 10 mM could a significant re-
duction of the maximal contractile effect of endothelin-1 be ob-
served (P = 0.001)
Fig. 2 Similar relaxing effect of increasing concentrations of
MgSO4 and MgC12 added to endothelia-l-precontracted porcine cil-
iary arteries (-10-8 M). NaCl, which has the same osmolarity as
MgSO4, did not evoke a relaxation. The relaxation to MgSO4 was
unaffected by the inhibitor of nitric oxide formation L-NAME
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Fig. 3 Effect of different extracellular CaC12 concentrations on
MgC12-induced relaxations. The relaxation-response curves to mag-
nesium were significantly shifted to the right in presence of increas-
ing concentrations of calcium (2.5 vs 5 mM: P<0.01; 5 vs 10 mM:
P<0.05)
effect of endothelin-1 be observed (E mzx = 80 ± 6%,
P = 0.001 vs control).
Magnesium relaxes endothelin-l-precontracted vessels
In arteries precontracted with endothelin-1 (10-8 M) in
magnesium-free medium, both MgC12 and MgSO 4 (10-5
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Fig. 4 Effect of different extracellular MgSO4 concentrations on
bradykinin-induced relaxations. In comparison to control experi-
ments (1.2 mM), the relaxation-response curve to bradykinin ap-
peared to be unaffected by changes of the extracellular magnesium
concentrations
-10-2 M) evoked complete concentration-dependent re-
laxations (MgC12: relaxmax = 95 ± 1%, pD2 =3.1 ± 0.1).
The two magnesium salts showed similar concentration-
relaxation curves, whereas NaCl had no relaxing effect,
excluding an unspecific effect of magnesium related to
changes in osmolarity. Furthermore, the relaxing effect
of MgSO4 was unaffected by the inhibitor of NO forma-
tion, L-NAME (10 M), demonstrating that in porcine
ciliary arteries NO is not involved in the relaxation
evoked by magnesium (Fig. 2).
Extracellular calcium concentration modulates relaxations
to magnesium
In vessels precontracted with endothelin-1 (_10-8 M) in
magnesium-free medium, changes of the calcium concen-
tration (2.5, 5, and 10 mM) in the medium affected the re-
laxation to MgCl2. Increasing extracellular calcium con-
centrations resulted in a rightward shift of the concentra-
tion-response curve (2.5 vs 5 mM: pD2 = 3.1 ± 0.1 vs
pD2 = 2.5 ± 0.1, P<0.01; 5 vs 10 mM: pD2 = 2.5 ± 0.1
vs pD2 = 2.0 ± 0.0, P < 0.05) without affecting the max-
imal relaxing effect of magnesium (Fig. 3).
Magnesium- and bradykinin-induced relaxations
In porcine ciliary arteries precontracted with endothelin-1
(-10-8 M), bradykinin (10-t 1-10-6 M) evoked concentra-
tion-dependent relaxations. In comparison to control ex-
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periments the relaxation-response curve to bradykinin
was not affected by changes in extracellular magnesium
concentrations, demonstrating that in porcine ciliary arte-
ries bradykinin-induced relaxations remain unaffected by
changes of the extracellular magnesium concentration
(Fig. 4).
Discussion
The present study demonstrates that in porcine ciliary ar-
teries, extracellular magnesium concentrations modulate
changes in contractile tone induced by endothelin-1.
The potent contracting effect of endothelin-1 was blunted
by elevated extracellular concentrations of magnesium,
while in endothelin-l-precontracted vessels magnesium
evoked potent and complete relaxations in a concentra-
tion-dependent manner. The magnesium-induced relax-
ations were shifted to the right by increasing the extracel-
lular concentration of calcium. Finally, relaxations to bra-
dykinin remained unaffected by changes in extracellular
concentrations of magnesium.
Magnesium has been shown to have calcium-antago-
nist-like properties [13, 14] and to inhibit calcium influx
through voltage-operated calcium channels [ 18, 31]. In
certain vascular beds calcium antagonists partially attenu-
ate the contraction to endothelin-1 [15], while they are
more potent in reversing an endothelin- 1-induced precon-
traction [33]. Therefore it has been suggested that in these
vascular beds the development of endothelin-1-induced
contractions is essentially dependent of the release of cal-
cium from intracellular storage sites, while the mainte-
nance of the contraction could involve voltage-operated
calcium channels [33]. In a similar way, the present study
shows that magnesium is less efficient in preventing the
development of a contraction to endothelin-1 (when add-
ed before the contraction) than in reversing a contraction
to endothelin-1 (when added once the contraction is fully
developed). Indeed, in the presence of 10 mM of magne-
sium, the contraction to 10 -8 M endothelin-1 was only
partially inhibited (Fig. 1), while once the contraction to
10-8 M endothelin-1 was fully developed, addition of
10 mM of magnesium evoked a complete relaxation of
the vessels (Fig. 2). A similar phenomenon has already
been reported in goat cerebral arteries [32], where magne-
sium reversed an endothelin-1-induced contraction, even
though it had no significant effect when added before
the contraction to endothelin-1.
The range of normal magnesium concentration in the
plasma of healthy subjects ranges between 0.7 and
1.1 mmol/l. At concentrations as high as 1.5 mM first he-
modynamic symptoms such as systemic hypotension and
tachycardia can be observed. With higher concentrations
(>7.5 mM) cardiac arrest can be induced [5]. The results
of this in vitro pharmacological study clearly show that
already at physiological magnesium concentrations
(1.0 mM), about 50% relaxation can be observed in ves-
sels precontracted with endothelin-1 in magnesium-free
medium, while to blunt the development of a contraction
evoked by endothelin-1 nonphysiological concentrations
of magnesium are needed.
Endothelin-l-precontracted vessels were fully and
concentration-dependently relaxed by MgSO4 and MgC12,
whereas in comparison NaCl had no relaxing effect, rul-
ing out an unspecific osmolarity effect of MgSO4 and
thereby demonstrating that the observed relaxing effect
was indeed due to magnesium (Fig. 2). With increasing
concentrations of calcium, the relaxation-response curve
to magnesium was shifted to the right, demonstrating that
the sensitivity to magnesium is closely related to the ex-
tracellular calcium concentration (Fig. 3). This corrobo-
rates studies in which it has been suggested that magne-
sium is able to regulate calcium flux across the vascular
smooth muscle cell membranes [3, 18, 30, 31]. Further-
more, this observation underlines the importance of the
calcium/magnesium concentration ratio in the mainte-
nance of contractions evoked by endothelin-1. Although
the exact mechanism of magnesium-induced relaxations
in porcine ciliary arteries remains to be further investigat-
ed, magnesium appears to have some calcium-antagonis-
tic properties.
The mechanism of the effect of magnesium on vascu-
lar tone is still debated, and in some vascular beds NO has
been shown to be involved in the relaxing effect of mag-
nesium [19]. In porcine ciliary arteries L-NAME, an in-
hibitor of NO formation, did not affect the magnesium-in-
duced relaxation, demonstrating that in these vessels the
relaxing effect of magnesium does not involve NO. This
is in agreement with some reports showing an endotheli-
um independency of the relaxations to magnesium [2].
In porcine ciliary arteries relaxations to bradykinin
were unaffected by magnesium (Fig. 4), demonstrating
that the NO production and action evoked by bradykinin
is unaffected by changes in the extracellular magnesium
concentration. This corroborates the lack of effect of cal-
cium antagonists on bradykinin-induced relaxations in
porcine ciliary arteries [24].
In conclusion, magnesium, which appears to share
some common features with calcium antagonists, is a po-
tent modulator of endothelin-1-induced contractions in
porcine ciliary arteries. As calcium antagonists have been
proposed for the treatment of some ocular vascular diseas-
es [8, 16, 26], magnesium, due to its calcium antagonist
properties, could be considered as a potential alternative
[7]. Such an approach has already been proposed for the
treatment of several vascular diseases, such as migraine
[4, 22].
Acknowledgements The authors thank Dr. H.P. Gurdan, F. Litzler
and F. German for technical help at the slaughterhouse (Basel, Swit-
zerland). This work was supported by the Swiss National Research
Foundation (grant 32-42564.94), the Schwickert Foundation, and the
Velux Foundation.
References
51
1. Alborch E, Salom JB, Perales AJ, Tor-
regrosa G, Miranda FJ, Alabadi JA, Jo-
ver T (1992) Comparison of the anti-
constrictor action of dihydropyridines
(nimodipine and nicardipine) and Mg t+
in isolated human cerebral arteries. Eur J
Pharmacol 229: 83-89
2. Aloamaka CP, Ezimokhai M, Morrison
J, Cherian T (1993) Effect of pregnancy
on relaxation of rat aorta to magnesium.
Cardiovasc Res 27: 1629-1633
3. Altura BM, Altura BT (1981) Magne-
sium ions and contraction of vascular
smooth muscle: relationship to some
vascular diseases. Fed Proc 40: 2672-
2679
4. Castelli S. Meossi C, Domenici R,
Fontana F, Stefani G (1993) Magnesium
in the prophylaxis of primary headache
and other periodic disorders in children.
Pediatr Med Chir 15: 481-488
5. Durlach J (1992) Magnesium Uber-
schuss. In: Durlach J (ed) Magnesium in
der klinischen Praxis. Fischer, Jena, pp
216-231
6. Farago M, Szabo C, Dora E, Horvath I,
Kovach AGB (1991) Contractile and
endothelium-dependent dilatory re-
sponses of cerebral arteries at various
extracellular magnesium concentrations.
J Cereb Blood Flow Metab 11: 161-164
7. Gaspar AZ, Gasser P, Flammer J (1995)
The influence of magnesium on visual
field and peripheral vasospasm in glau-
coma. Ophthalmologica 209: 11-13
8. Gasser P. Flammer J (1990) Short- and
long-term effect of nifedipine on the
visual field in patients with presumed
vasospasm. J Int Med Res 18: 334-339
9. Gold ME, Buga GM, Wood KS, Byrns
RE, Chaudhuri G, Ignarro LJ (1990)
Antagonistic modulatory roles of mag-
nesium and calcium on release of en-
dothelium-derived relaxing factor and
smooth muscle tone. Circ Res 66: 355-
366
10. Goto K, Kasuya Y, Matsuki N, Takuwa
Y, Kurihara H, Ishikawa T, Kimura S,
Yanagisawa M, Masaki T (1989) Endo-
thelin activates the dihydropyridine-
sensitive, voltage-dependent Ca z+ chan-
nel in vascular smooth muscle. Proc
Natl Acad Sci USA 86: 3915-3918
11. Haefliger IO, Flammer J, Luscher TF
(1992) Nitric oxide and endothelin-1 are
important regulators of human ophthal-
mic artery. Invest Ophthalmol Vis Sci
33: 2340-2343
12. Haefliger I0, Flammer J, Luscher TF
(1993) Heterogeneity of endothelium-
dependent regulation in ophthalmic and
ciliary arteries. Invest Ophthalmol Vis
Sci 34: 1722-1730
13. Iseri LT, French JH (1984) Magnesium:
nature's physiologic calcium blocker.
Am Heart J 108: 188-194
14. Karaki H, Hatano K, Weiss GB (1983)
Effects of magnesium on 45Ca uptake
and release at different sites in rabbit
aortic smooth muscle. Pflugers Arch
398: 27-32
15. Kiowski W, Luscher TF, Linder L,
Bnhler FR (1991) Endothelin-l-induced
vasoconstriction in humans: reversal by
calcium channel blockade but not by
nitrovasodilators or endothelium derived
relaxing factor. Circulation 83: 469-475
16. Kitazawa Y, Shirai H, Go FJ (1989) The
effect of calcium-antagonists on visual
field in low-tension glaucoma. Graefe's
Arch Clin Exp Ophthalmol 227: 408-
412
17. Ku DD, Ann SH (1991) Differential ef-
fects of magnesium on basal and ago-
nist-induced EDRF relaxation in canine
coronary arteries. J Cardiovasc Phar-
macol 17: 999-1006
18. Kumasaka D, Lindeman KS, Clancy J,
Lande B, Croxton TL, Hirshman CA
(1996) MgSO4 relaxes porcine airway
smooth muscle by reducing Caz+ entry.
Am J Physiol 270: L469-74
19. Laurant P, Berthelot A (1994) Influence
of endothelium on Mgt -induced relax-
ation in noradrenaline-contracted aorta
from DOCA-salt hypertensive rat. Eur J
Pharmacol 258: 167-172
20. Liischer TF (1990) In: Ldscher TF,
Vanhoutte PM (eds) The endothelium:
modulator of cardiovascular function.
CRC Press, Boca Raton, pp 1-228
21. Marsden PA, Danthuluri NR, Brenner
BM, Ballermann, BJ Brock TA (1989)
Endothelin action on vascular smooth
muscle involves inositol triphosphate
and calcium mobilization. Biochem
Biophys Res Commun 158: 86-93
22. Mauskop A, Altura BT, Cracco RQ,
Altura BT (1995) Intravenous magne-
sium sulphate relieves migraine attacks
in patients with low serum ionized
magnesium levels: a pilot study. Clin
Sci Colch 89: 633-636
23. Meyer P, Flammer J, Luscher TF (1993)
Endothelium-dependent regulation of
the ophthalmic microcirculation in the
perfused porcine eye: role of nitric oxide
and endothelins. Invest Ophthalmol Vis
Sci 34: 3614-3621
24. Meyer P, Lang MG, Flammer J, Luscher
TF (1995) Effects of calcium channel
blockers on the response to endothelin-
1, bradykinin and sodium nitroprusside
in porcine ciliary arteries. Exp Eye Res
60: 505-510
25. Mulvani MJ, Halpern W (1976) Me-
chanical properties of vascular smooth
muscle in situ. Nature 260: 617
26. Netland PA, Chaturvedi N, Dreyer EB
(1993) Calcium channel blockers in the
management of low-tension and open-
angle glaucoma. Am J Ophthalmol 115:
608-613
27. Nyborg NC, Prieto D, Benedito S,
Nielsen PJ (1991) Endothelin-l-induced
contraction of bovine retinal small arte-
ries is reversible and abolished by ni-
trendipine. Invest Ophthalmol Vis Sci
32: 27-31
28. Palmer RMJ, Ashton DS, Moncada S
(1988) Vascular endothelial cells syn-
thesize nitric oxide from L-arginine.
Nature 333: 664-666
29. Resink TJ, Scott-Burden T, Bnhler FR
(1988) Endothelin stimulates phospho-
lipase C in cultured vascular smooth
muscle cells. Biochem Biophys Res
Commun 157: 1360-1368
30. Skajaa K, Forman A, Andersson KE
(1990) Effects of magnesium on isolated
human fetal and maternal uteroplacental
vessels. Acta Physiol Scand 139: 551-
559
31. Skajaa K, Svane D, Andersson KE,
Forman A (1990) Effects of magnesium
and isradipine on contractile activation
induced by the thromobxane A2 analog
U46619 in human utero-placental arte-
ries in term pregnancy. Am J Obstet
Gynecol 163: 1323-1333
32. Torregrosa G, Pearles AJ, Salom JB,
Miranda FJ, Barbera MD, Alborch E
(1994) Different effects of Mg t on en-
dothelin-l- and 5-hydroxytryptamine-
elicited response in goat cerebrovascular
bed. J Cardiovasc Pharmacol 23: 1004-
1010
33. Yang Z, Bauer E, Von Segesser L, Stulz
P. Turina M, Luscher TF (1990) Dif-
ferent mobilization of calcium in endo-
thelin-1-induced contractions in human
arteries and veins: effects of calcium
antagonists. J Cardiovasc Pharmacol 16:
654-660
34. Zhu P, Beny JL, Flammer J, Luscher TF,
Haefliger IO (1997) Relaxation by bra-
dykinin in porcine ciliary artery: role of
nitric oxide and K-channels. Invest
Ophthalmol Vis Sci 38: 1761-1767
